These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2293909)

  • 21. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
    Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
    Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective study of the relationship between relapse of hyperthyroid Graves' disease after antithyroid drugs and HLA haplotype.
    Allannic H; Fauchet R; Lorcy Y; Gueguen M; Le Guerrier AM; Genetet B
    J Clin Endocrinol Metab; 1983 Oct; 57(4):719-22. PubMed ID: 6688428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA antigens in Greek patients with thyrotoxicosis (Graves' disease and toxic nodular goiter).
    Papasteriades C; Alevizaki-Harhalaki MN; Economidou J; Ikkos DG
    J Endocrinol Invest; 1984 Aug; 7(4):283-6. PubMed ID: 6594386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-polarized cell surface expression of HLA-A,B,C and HLA-DR antigens in Graves' thyroid follicle cells.
    Mölne J; Nilsson M; Jansson S; Hansson G; Ericson LE
    Autoimmunity; 1991; 10(3):189-99. PubMed ID: 1756224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of HLA antigens in the manifestation and course of Graves' disease.
    Stenszky V; Kozma L; Balazś C; Bear JC; Farid NR
    Mol Biol Med; 1986 Feb; 3(1):53-62. PubMed ID: 3485758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity by cluster analysis techniques of Graves' patients typed for HLA DR and IgG heavy chain markers.
    Frecker MF; Preus M; Kozma L; Krasrits E; Stenszky V; Balazś C; Farid NR
    Mol Biol Med; 1986 Feb; 3(1):63-71. PubMed ID: 3083192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of HLA-DR antigens by thyroid cells: the effect of Graves' IgG.
    Bodolay E; Szegedi G; Suranyi P; Juhasz F; Stenszky V; Balazs C; Farid NR
    Immunol Lett; 1987 May; 15(1):77-81. PubMed ID: 3111991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-BW35 and B5 in Japanese patients with Graves' disease.
    Kawa A; Nakamura S; Nakazawa M; Sakaguchi S; Kawabata T; Maeda Y; Kanehisa T
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):754-7. PubMed ID: 579034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Graves' disease and HLA: clinical and epidemiologic associations.
    Farid NR; Stone E; Johnson G
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):535-44. PubMed ID: 6894412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HLA antigens in Asian Indian patients with Graves' disease.
    Tandon N; Mehra NK; Taneja V; Vaidya MC; Kochupillai N
    Clin Endocrinol (Oxf); 1990 Jul; 33(1):21-6. PubMed ID: 2401095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-DR antigens in Japanese with Hashimoto's thyroiditis and Graves' disease.
    Azuma Y; Sakurami T; Ueno Y; Ohishi M; Saji H; Terasaki PI; Park MS
    Endocrinol Jpn; 1982 Aug; 29(4):423-7. PubMed ID: 6961032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves' disease in a Caucasian population.
    Yanagawa T; Mangklabruks A; Chang YB; Okamoto Y; Fisfalen ME; Curran PG; DeGroot LJ
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1569-74. PubMed ID: 8501164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association of HLA -A, -B, and -DRB1 genotypes with Graves' disease in Taiwanese people.
    Huang SM; Wu TJ; Lee TD; Yang EK; Shaw CK; Yeh CC
    Tissue Antigens; 2003 Feb; 61(2):154-8. PubMed ID: 12694583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of therapeutic response to radioactive iodine in Graves' disease using TSH-receptor antibodies and HLA-status.
    Davies TF; Platzer M; Farid NR
    Clin Endocrinol (Oxf); 1982 Feb; 16(2):183-91. PubMed ID: 6121637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Properdin factor B (Bf) and glyoxalase in Graves' disease.
    Allannic H; Fauchet R; Lorcy Y; Phengsavath H; Gueguen M; Knoi TD; Genetet B; Le Gall JY
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):57-61. PubMed ID: 6572032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA Bw46 and DR9 associations in Graves' disease of Chinese patients are age- and sex-related.
    Yeo PP; Chan SH; Thai AC; Ng WY; Lui KF; Wee GB; Tan SH; Lee BW; Wong HB; Cheah JS
    Tissue Antigens; 1989 Sep; 34(3):179-84. PubMed ID: 2595722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease.
    Matsunaga M; Eguchi K; Fukuda T; Kurata A; Tezuka H; Shimomura C; Otsubo T; Ishikawa N; Ito K; Nagataki S
    J Clin Endocrinol Metab; 1986 Apr; 62(4):723-8. PubMed ID: 3081570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The HLA B w4/w6 diallelic system in Graves' disease.
    Farid NR; Barnard JM; Sampson L; Noel EP; Marshall WH
    Tissue Antigens; 1978 May; 11(5):394-8. PubMed ID: 581239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyrotropin Receptor-Specific Lymphocytes in Adenovirus-TSHR-Immunized Native and Human Leukocyte Antigen-DR3-Transgenic Mice and in Graves' Disease Patient Blood.
    Degen H; Gavvovidis I; Blankenstein T; Uhland K; Ungerer M
    Thyroid; 2021 Jun; 31(6):950-963. PubMed ID: 33208049
    [No Abstract]   [Full Text] [Related]  

  • 40. HLA-DR3 and DRw6: prognostic factors for the incidence of hypothyroidism in Graves' disease after radioiodine treatment.
    Althaus B; Straub JJ; Neri TM; Hauenstein M; Müller-Brand J; Berger W; Farid NR
    Acta Endocrinol (Copenh); 1986 Nov; 113(3):323-8. PubMed ID: 3788412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.